Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6068 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0013 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-646 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-385 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-34 |
filingDate |
2001-12-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac38d29119668f12aeabfedb273c88bc |
publicationDate |
2005-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2005100901-A1 |
titleOfInvention |
Vaccine for treating nicotine addiction |
abstract |
The present invention provides active or passive forms of immunotherapy against the metabolites of nicotine. For example, there is provided a vaccine comprising a metabolite of nicotine, and in particular those vaccines that comprise cotinine, which is used for immunotherapy of nicotine addiction. |
priorityDate |
2000-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |